ALPS Medical Breakthroughs ETF is a ETF series of ALPS ETF TRUST (series S000047823). Net assets $161.8M as of 2026-05-31. Index fund.
Showing 15 of 89 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Alkermes Plc | — | $7.2M | 447.80% |
| Kymera Therapeutics Inc | — | $6.9M | 423.49% |
| Celcuity Inc | — | $6.3M | 391.70% |
| Mirum Pharmaceuticals Inc | — | $6.3M | 390.20% |
| Spyre Therapeutics Inc | — | $6.0M | 367.78% |
| Cg Oncology Inc | — | $5.4M | 335.07% |
| Apogee Therapeutics Inc | — | $4.7M | 293.05% |
| Xenon Pharmaceuticals Inc | — | $4.7M | 290.06% |
| Travere Therapeutics Inc | — | $4.5M | 277.18% |
| Dianthus Therapeutics Inc | — | $4.3M | 263.52% |
| Newamsterdam Pharma Co Nv | — | $4.0M | 246.71% |
| Viking Therapeutics Inc | — | $3.9M | 241.02% |
| Crinetics Pharmaceuticals Inc | — | $3.8M | 237.07% |
| Acadia Pharmaceuticals Inc | — | $3.8M | 235.27% |
| Edgewise Therapeutics Inc | — | $3.8M | 233.46% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $161.8M |
| 2026-02-28 | $138.0M |
| 2025-11-30 | $104.6M |
| 2025-08-31 | $81.0M |
| 2025-05-31 | $81.2M |
| 2025-02-28 | $94.1M |
| 2024-11-30 | $123.2M |
| 2024-08-31 | $114.1M |